E907:XETRA:XETRA-Lyxor 1 MDAX (DR) UCITS ETF I (EUR)

ETF | Others |

Last Closing

USD 131.22

Change

-0.56 (-0.42)%

Market Cap

USD 0.13B

Volume

2.01K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-10-01 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XM1D:XETRA Xtrackers MSCI Japan UCITS ETF..

+0.41 (+0.79%)

USD 501.76B
LCUJ:XETRA Lyxor Core MSCI Japan (DR) UCI..

+0.13 (+0.77%)

USD 191.96B
PRAJ:XETRA Amundi Index Solutions - Amund..

+0.26 (+0.97%)

USD 177.46B
PR1J:XETRA Amundi Prime Japan UCITS ETF D..

+0.21 (+0.73%)

USD 177.46B
XDJP:XETRA Xtrackers Nikkei 225 UCITS ETF..

+0.10 (+0.41%)

USD 157.79B
8R80:XETRA Amundi Index Solutions - Amund..

+0.02 (+0.01%)

USD 101.19B
JARI:XETRA Amundi Index Solutions - Amund..

+0.01 (+0.01%)

USD 100.74B
UIM5:XETRA UBS (Lux) Fund Solutions - MSC..

+0.40 (+0.78%)

USD 85.64B
EUNL:XETRA iShares Core MSCI World UCITS ..

+0.19 (+0.20%)

USD 84.07B
SXR8:XETRA iShares Core S&P 500 UCITS ETF..

+1.48 (+0.27%)

USD 80.38B

ETFs Containing E907:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -5.39% 8% B- 16% F
Dividend Return 1.73% 59% D- 40% F
Total Return -3.66% 9% A- 16% F
Trailing 12 Months  
Capital Gain 0.32% 11% F 19% F
Dividend Return 1.83% 50% F 34% F
Total Return 2.16% 13% F 21% F
Trailing 5 Years  
Capital Gain -3.17% 24% F 31% F
Dividend Return 4.29% 51% F 25% F
Total Return 1.12% 27% F 32% F
Average Annual (5 Year Horizon)  
Capital Gain 0.46% N/A N/A 31% F
Dividend Return 1.03% N/A N/A 32% F
Total Return 0.57% N/A N/A 27% F
Risk Return Profile  
Volatility (Standard Deviation) 19.60% N/A N/A 33% F
Risk Adjusted Return 5.24% N/A N/A 29% F
Market Capitalization 0.13B 37% F 34% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.